Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ingredia is a global dairy company specializing in the development and manufacture of innovative dairy-derived ingredients for the health, nutrition, and food industries. The company is well-known for its nutritional division, which produces bioactive proteins and peptides backed by clinical studies, such as Lactium, a milk protein hydrolysate used for stress management and sleep improvement. Ingredia operates as a subsidiary of the French dairy cooperative La Prospérité Fermière, leveraging advanced membrane filtration and fractionation technologies to isolate high-value components like micellar casein and native whey proteins. Their product portfolio targets diverse health areas including cognitive health, immunity, and sports nutrition, positioning them as a key supplier for the nutraceutical and functional food markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ingredia Nutritional.